Table 6.
Ischemic heart disease | Asymptomatic patient with normal LVEF at 12 months after an ACS or revascularization |
Asymptomatic with incomplete revascularization and a negative test for ischemia or good prognosis at 12 months of follow-up | |
Stable angina with normal LVEF and a negative test for ischemia or good prognosis at 12 months of follow-up | |
Heart failure | Patients preferably in primary care follow-up |
Nonadvanced HF patients: • NYHA I-II • Without decompensations in the last 12 months (have not needed to visit hospital or emergency department) • Optimized pharmacological and device management. Diuretics according to congestion | |
Patients in cardiology follow-up with coordinated support from primary care | |
• Patients in the pharmacological titration phase • Mild HF decompensations | |
Arrhythmias | Patients with persistent or permanent atrial fibrillation that are stable or have few symptoms under treatment |
Patients with supraventricular tachycardias, isolated supraventricular extrasystoles, sinus tachycardia, and nonsustained tachycardias (< 30 seconds) without known heart disease and with normal electrocardiogram | |
Patients with isolated ventricular extrasystoles but without other symptoms of heart disease (especially young patients) | |
Secondary arrhythmias with vagal stimulation, well-tolerated | |
Conduction disorders, such as second-grade Wenckebach-type atrioventricular type block or bifascicular block, especially if they are asymptomatic |
ACS, acute coronary syndrome; HF, heart failure; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association.